SARS-CoV-2 and the cardiovascular system
| dc.creator | Hafiane, Anouar | |
| dc.date.accessioned | 2020-10-05T16:58:46Z | |
| dc.date.available | 2020-10-05T16:58:46Z | |
| dc.date.issued | 2020-11 | |
| dc.description.abstract | The coronavirus disease COVID-19 is a public health emergency caused by a novel coronavirus named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). SARS-CoV-2 infection uses the angiotensin-converting enzyme 2 (ACE2) receptor, and typically spreads through the respiratory tract. Invading viruses can elicit an exaggerated host immune response, frequently leading to a cytokine storm that may be fueling some COVID-19 death. This response contributes to multi-organ dysfunction. Accumulating data points to an increased cardiovascular disease morbidity, and mortality in COVID-19 patients. This brief review explores potential available evidence regarding the association between COVID-19, and cardiovascular complications. | pt_BR |
| dc.identifier.citation | HAFIANE, A. SARS-CoV-2 and the cardiovascular system. Clinica Chimica Acta, [S.l.], v. 510, p. 311-316, Nov. 2020. | pt_BR |
| dc.identifier.uri | https://repositorio.ufla.br/handle/1/43318 | |
| dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0009898120303430 | pt_BR |
| dc.language | en_US | pt_BR |
| dc.publisher | Elsevier | pt_BR |
| dc.rights | openAccess | pt_BR |
| dc.source | Clinica Chimica Acta | pt_BR |
| dc.subject | COVID-19 | pt_BR |
| dc.subject | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | pt_BR |
| dc.subject | Myocardial injury | pt_BR |
| dc.subject | Angiotensin-converting enzyme 2 (ACE2) | pt_BR |
| dc.subject | Severe acute respiratory syndrome | pt_BR |
| dc.subject | Troponin | pt_BR |
| dc.title | SARS-CoV-2 and the cardiovascular system | pt_BR |
| dc.type | Artigo | pt_BR |
Arquivos
Licença do pacote
1 - 1 de 1
Carregando...
- Nome:
- license.txt
- Tamanho:
- 953 B
- Formato:
- Item-specific license agreed upon to submission
- Descrição:
